Lista de obras - J Graham - Dominio Público Uruguay

A non-invasive, relocatable stereotactic frame for fractionated radiotherapy and multiple imaging

artículo científico publicado en 1991

A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: a study by the Scottish Gynaecological Cancer Trials Group (SGCTG).

artículo científico publicado en 2005

A randomised trial of accelerated radiotherapy for localised invasive bladder cancer

artículo científico publicado en 2004

AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies

artículo científico publicado en 2015

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

artículo científico publicado en 2015

Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma: results of a phase III randomised European Organisation for Research and Treatment of Ca

artículo científico publicado en 2013

Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?

artículo científico publicado en 2009

Authors' reply to Steele and colleagues

artículo científico publicado en 2015

Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

artículo científico publicado en 2016

Case of the month: a calcified brain.

artículo científico publicado en 1993

Chemotherapy for ovarian cancer--a consensus statement on standard practice. ⬇️

artículo científico publicado en 1998

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

artículo científico publicado en 2016

Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. Scottish Gynaecological Cancer Trials Group.

artículo científico publicado en 1999

Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer.

artículo científico publicado en 2009

Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer

artículo científico publicado en 2001

Effect of adjuvant trastuzumab on pregnancy

scientific article published on 01 January 2006

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

artículo científico publicado en 2014

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

artículo científico publicado en 2007

Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer

artículo científico publicado en 2007

Familial breast cancer: summary of updated NICE guidance

artículo científico publicado en 2013

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity

scientific article published on 06 June 2019

Fractionated stereotactic external beam radiotherapy in the management of brain metastases.

artículo científico publicado en 1993

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

artículo científico publicado en 2015

Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.

artículo científico publicado en 2004

Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397).

artículo científico publicado en 2009

Nasty or Nice? Findings from a UK Survey to evaluate the impact of the National Institute for Health and Clinical Excellence (NICE) clinical guidelines on the management of prostate cancer.

artículo científico publicado en 2012

National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting

artículo científico publicado en 2018

Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancer.

artículo científico publicado en 2007

Patient life-expectancy: a vital element in planning treatment?

artículo científico publicado en 2004

Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester)

artículo científico publicado en 1986

Practical management issues in bilateral testicular cancer.

artículo científico publicado en 2004

Prescribing strong opioids for pain in adult palliative care: summary of NICE guidance.

artículo científico publicado en 2012

Prostate cancer: How good are guidelines for localized prostate cancer?

scientific article published on 03 February 2015

Prostate cancer: summary of updated NICE guidance

artículo científico publicado en 2014

Re-irradiation of soft-tissue sarcoma

artículo científico publicado en 1992

Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985 ⬇️

artículo científico publicado el 1 de febrero de 1988

Return of the postcode lottery

artículo científico publicado en 2010

Spontaneous rupture of the spleen secondary to metastatic teratoma.

artículo científico publicado en 1996

Suspected cancer (part 1--children and young adults): visual overview of updated NICE guidance

artículo científico publicado en 2015

Suspected cancer (part 2--adults): reference tables from updated NICE guidance

scientific article published on 23 June 2015

The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial

artículo científico publicado en 2018

The assessment of patient life-expectancy: how accurate are urologists and oncologists?

scientific article published on 01 April 2005

The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397)

article

The effect of verapamil on the pharmacokinetics of adriamycin.

artículo científico publicado en 1986

The longitudinal relationship between the systemic inflammatory response, circulating T-lymphocytes, interleukin-6 and -10 in patients undergoing immunotherapy for metastatic renal cancer

artículo científico publicado en 2008

The role of lymphography in the management of carcinoma of the endometrium

scientific article published on 01 September 1989

Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial

artículo científico publicado en 2018

Whole body doses from linear accelerator-based stereotactic radiotherapy

scientific article published on 01 June 1997

Lista de obras de J Graham

A non-invasive, relocatable stereotactic frame for fractionated radiotherapy and multiple imaging

A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: a study by the Scottish Gynaecological Cancer Trials Group (SGCTG).

A randomised trial of accelerated radiotherapy for localised invasive bladder cancer

AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma: results of a phase III randomised European Organisation for Research and Treatment of Ca

Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?

Authors' reply to Steele and colleagues

Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Case of the month: a calcified brain.

Chemotherapy for ovarian cancer--a consensus statement on standard practice. ⬇️

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. Scottish Gynaecological Cancer Trials Group.

Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer.

Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer

Effect of adjuvant trastuzumab on pregnancy

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer

Familial breast cancer: summary of updated NICE guidance

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity

Fractionated stereotactic external beam radiotherapy in the management of brain metastases.

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.

Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397).

Nasty or Nice? Findings from a UK Survey to evaluate the impact of the National Institute for Health and Clinical Excellence (NICE) clinical guidelines on the management of prostate cancer.

National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting

Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancer.

Patient life-expectancy: a vital element in planning treatment?

Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester)

Practical management issues in bilateral testicular cancer.

Prescribing strong opioids for pain in adult palliative care: summary of NICE guidance.

Prostate cancer: How good are guidelines for localized prostate cancer?

Prostate cancer: summary of updated NICE guidance

Re-irradiation of soft-tissue sarcoma

Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985 ⬇️

Return of the postcode lottery

Spontaneous rupture of the spleen secondary to metastatic teratoma.

Suspected cancer (part 1--children and young adults): visual overview of updated NICE guidance

Suspected cancer (part 2--adults): reference tables from updated NICE guidance

The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial

The assessment of patient life-expectancy: how accurate are urologists and oncologists?

The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397)

The effect of verapamil on the pharmacokinetics of adriamycin.

The longitudinal relationship between the systemic inflammatory response, circulating T-lymphocytes, interleukin-6 and -10 in patients undergoing immunotherapy for metastatic renal cancer

The role of lymphography in the management of carcinoma of the endometrium

Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial

Whole body doses from linear accelerator-based stereotactic radiotherapy